Addressing 'Drug Lag' in Japan: Urgent Need to Strengthen New Drug Development
Currently, there is growing concern in Japan regarding the issue of "drug lag." Drug lag refers to a situation where new drugs approved overseas are not immediately available for use in Japan. This has become a major social issue, as it means patients may be unable to access the latest treatments.
To improve this situation, the government, companies, and universities have begun discussions on strengthening the country's drug discovery capabilities through collaborative efforts. Being selected as a country for international joint clinical trials is considered a key factor in resolving this issue.
There is a demand for the Japanese pharmaceutical industry to become globally competitive and to create an environment where new overseas drugs can be introduced domestically more quickly. To achieve this, it is necessary to review the clinical trial system and establish a framework that allows for smoother development of new drugs.
Many citizens are watching to see what measures will be implemented through the unified efforts of industry, government, and academia. Improving Japan's drug discovery environment is an urgent priority for a future where patients can receive the latest medical care with peace of mind.